⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13598576 | 1.00 | — | — | |
| SCHEMBL2760263 | 0.70 | — | — | |
| SCHEMBL8298016 | 0.70 | — | — | |
| SCHEMBL12765086 | 0.70 | — | — | |
| SCHEMBL13035835 | 0.70 | — | — | |
| SCHEMBL2009653 | 0.70 | — | — | |
| SCHEMBL13181713 | 0.70 | — | — | |
| SCHEMBL5487565 | 0.70 | — | — | |
| SCHEMBL20207147 | 0.70 | — | — | |
| SCHEMBL3941312 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507727-B2 | Substituted quinobenzoxazine analogs and methods of using thereof | CYLENE PHARMACEUTICALS, INC. (US) | 2009-03-24 | — | — | US | disclosed |
| US-7354916-B2 | Substituted quinobenzoxazine analogs | CYLENE PHARMACEUTICALS (US) | 2008-04-08 | — | — | US | disclosed |
| EP-1773346-A1 | SUBSTITUTED QUINOBENZOXAZINE ANALOGS AND METHODS OF USING THEREOF | Cylene Pharmaceuticals, Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006078317-A1 | SUBSTITUTED QUINOBENZOXAZINE ANALOGS AND METHODS OF USING THEREOF | CYLENE PHARMACEUTICALS, INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| US-20060029950-A1 | Substituted quinobenzoxazine analogs and methods of using thereof | CYLENE PHARMACEUTICALS, INC. | 2006-02-09 | — | — | US | disclosed |
| US-20050085468-A1 | Substituted quinobenzoxazine analogs | CYLENE PHARMACEUTICALS | 2005-04-21 | — | — | US | disclosed |